Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)
Condition(s):Seasonal Allergic RhinitisLast Updated:February 9, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Seasonal Allergic RhinitisLast Updated:February 9, 2022Completed
Condition(s):AsthmaLast Updated:October 13, 2023Completed
Condition(s):Nasal PolypsLast Updated:February 16, 2022Completed
Condition(s):Invasive Breast CancerLast Updated:October 3, 2019Completed
Condition(s):Plaque PsoriasisLast Updated:November 3, 2022Suspended
Condition(s):AsthmaLast Updated:July 8, 2008Completed
Condition(s):Chronic RhinitisLast Updated:July 28, 2023Recruiting
Condition(s):Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation TherapyLast Updated:August 1, 2016Completed
Condition(s):Perennial Allergic RhinitisLast Updated:January 6, 2009Terminated
Condition(s):Chronic SinusitisLast Updated:July 18, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.